Achieve Life Sciences Inc.

0.4098+0.0043+1.06%Vol 43.24K1Y Perf -90.16%
May 29th, 2020 10:20 DELAYED
BID0.4055 ASK0.4099
Open0.4095 Previous Close0.4055
Pre-Market- After-Market-
 - -%  - -%
Target Price
4.25 
Analyst Rating
Strong Buy 1.00
Potential %
938.61 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap15.37M 
Earnings Rating
Neutral
Price Range Ratio 52W %
4.38 
Earnings Date
14th May 2020

Today's Price Range

0.40550.4100

52W Range

0.22574.43

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-3.45%
1 Month
-3.43%
3 Months
-15.52%
6 Months
-55.92%
1 Year
-90.16%
3 Years
-98.98%
5 Years
-99.83%
10 Years
-99.98%

TickerPriceChg.Chg.%
ACHV0.40980.00431.06
AAPL317.56-0.6900-0.22
GOOG1 418.701.97000.14
MSFT181.34-0.0600-0.03
XOM45.00-0.0400-0.09
WFC26.96-0.2600-0.96
JNJ146.89-0.0800-0.05
FB223.56-1.9000-0.84
GE6.58-0.2000-2.95
JPM98.85-1.0100-1.01
Earnings HistoryEstimateReportedSurprise %
Q01 2020--0.11-
Q04 2019-0.27-0.30-11.11
Q03 2019-0.22-0.45-104.55
Q02 2019-0.33-0.50-51.52
Q01 2019--0.88-
Q04 2018--0.55-
Q03 2018--0.71-
Q04 2017--3.20-
Earnings Per EndEstimateRevision %Trend
12/2019 QR-0.27-80.00Negative
12/2019 QR-0.200.00-
12/2020 FY-0.5859.44Positive
12/2021 FY-0.2064.29Positive
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume43.24K
Shares Outstanding37.52M
Trades Count70
Dollar Volume17.98K
Avg. Volume1.38M
Avg. Weekly Volume410.48K
Avg. Monthly Volume766.52K
Avg. Quarterly Volume810.93K

Achieve Life Sciences Inc. (NASDAQ: ACHV) stock closed at 0.4055 per share at the end of the most recent trading day (a -1.22% change compared to the prior day closing price) with a volume of 249.24K shares and market capitalization of 15.37M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 13 people. Achieve Life Sciences Inc. CEO is Richard Alistair Balfour Stewart.

The one-year performance of Achieve Life Sciences Inc. stock is -90.16%, while year-to-date (YTD) performance is -23.49%. ACHV stock has a five-year performance of -99.83%. Its 52-week range is between 0.2257 and 4.43, which gives ACHV stock a 52-week price range ratio of 4.38%

Achieve Life Sciences Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 1.04, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -88.68%, a ROC of -107.45% and a ROE of -109.72%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Achieve Life Sciences Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Achieve Life Sciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Achieve Life Sciences Inc. is Strong Buy (1), with a target price of $4.25, which is +938.61% compared to the current price. The earnings rating for Achieve Life Sciences Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Achieve Life Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Achieve Life Sciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 23.87, ATR14 : 0.04, CCI20 : -12.72, Chaikin Money Flow : 0.16, MACD : 0.01, Money Flow Index : 45.08, ROC : -5.70, RSI : 51.42, STOCH (14,3) : 56.98, STOCH RSI : 0.20, UO : 49.99, Williams %R : -43.02), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Achieve Life Sciences Inc. in the last 12-months were: John Bencich (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a United States based clinical-stage biopharmaceutical company. It is focused on the development of novel next-generation cancer therapeutics. The company's product candidate is apatorsen which is designed to block the production of heat shock protein 27, or Hsp27, a protein that promotes treatment resistance in cancer. The group has business offices located in Bothell, Washington and Vancouver, British Columbia.

CEO: Richard Alistair Balfour Stewart

Teplephone: +1 604) 210-2217

Address: 1040 West Georgia Street, Bothell V6E 4H1, WA, USA

Number of employees: 13

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

59%41%

Bearish Bullish

49%51%

News

Stocktwits